Fingerprint
Dive into the research topics of 'Bruton’s tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bruton’s tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL)
Philip A. Thompson, Jan A. Burger
Research output: Contribution to journal › Review article › peer-review
57
Scopus
citations